These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 23241245)
1. NIPP1 maintains EZH2 phosphorylation and promoter occupancy at proliferation-related target genes. Minnebo N; Görnemann J; O'Connell N; Van Dessel N; Derua R; Vermunt MW; Page R; Beullens M; Peti W; Van Eynde A; Bollen M Nucleic Acids Res; 2013 Jan; 41(2):842-54. PubMed ID: 23241245 [TBL] [Abstract][Full Text] [Related]
2. The phosphatase interactor NIPP1 regulates the occupancy of the histone methyltransferase EZH2 at Polycomb targets. Van Dessel N; Beke L; Görnemann J; Minnebo N; Beullens M; Tanuma N; Shima H; Van Eynde A; Bollen M Nucleic Acids Res; 2010 Nov; 38(21):7500-12. PubMed ID: 20671031 [TBL] [Abstract][Full Text] [Related]
3. The deletion of the protein phosphatase 1 regulator NIPP1 in testis causes hyperphosphorylation and degradation of the histone methyltransferase EZH2. Ferreira M; Verbinnen I; Fardilha M; Van Eynde A; Bollen M J Biol Chem; 2018 Nov; 293(47):18031-18039. PubMed ID: 30305391 [TBL] [Abstract][Full Text] [Related]
4. The transcriptional repressor NIPP1 is an essential player in EZH2-mediated gene silencing. Nuytten M; Beke L; Van Eynde A; Ceulemans H; Beullens M; Van Hummelen P; Fuks F; Bollen M Oncogene; 2008 Feb; 27(10):1449-60. PubMed ID: 17724462 [TBL] [Abstract][Full Text] [Related]
5. PP1 regulatory subunit NIPP1 regulates transcription of E2F1 target genes following DNA damage. Hanaki S; Habara M; Masaki T; Maeda K; Sato Y; Nakanishi M; Shimada M Cancer Sci; 2021 Jul; 112(7):2739-2752. PubMed ID: 33939241 [TBL] [Abstract][Full Text] [Related]
6. Nuclear inhibitor of protein phosphatase-1 (NIPP1) directs protein phosphatase-1 (PP1) to dephosphorylate the U2 small nuclear ribonucleoprotein particle (snRNP) component, spliceosome-associated protein 155 (Sap155). Tanuma N; Kim SE; Beullens M; Tsubaki Y; Mitsuhashi S; Nomura M; Kawamura T; Isono K; Koseki H; Sato M; Bollen M; Kikuchi K; Shima H J Biol Chem; 2008 Dec; 283(51):35805-14. PubMed ID: 18842582 [TBL] [Abstract][Full Text] [Related]
7. Protein phosphatase PP1-NIPP1 activates mesenchymal genes in HeLa cells. Van Dessel N; Boens S; Lesage B; Winkler C; Görnemann J; Van Eynde A; Bollen M FEBS Lett; 2015 May; 589(12):1314-21. PubMed ID: 25907536 [TBL] [Abstract][Full Text] [Related]
8. The transcriptional repression by NIPP1 is mediated by Polycomb group proteins. Roy N; Van Eynde A; Beke L; Nuytten M; Bollen M Biochim Biophys Acta; 2007; 1769(9-10):541-5. PubMed ID: 17804093 [TBL] [Abstract][Full Text] [Related]
9. NIPP1-mediated interaction of protein phosphatase-1 with CDC5L, a regulator of pre-mRNA splicing and mitotic entry. Boudrez A; Beullens M; Groenen P; Van Eynde A; Vulsteke V; Jagiello I; Murray M; Krainer AR; Stalmans W; Bollen M J Biol Chem; 2000 Aug; 275(33):25411-7. PubMed ID: 10827081 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of PP1-NIPP1 limits the capacity of cells to repair DNA double-strand breaks. Winkler C; Rouget R; Wu D; Beullens M; Van Eynde A; Bollen M J Cell Sci; 2018 Jul; 131(13):. PubMed ID: 29898919 [TBL] [Abstract][Full Text] [Related]
11. The protein phosphatase-1 (PP1) regulator, nuclear inhibitor of PP1 (NIPP1), interacts with the polycomb group protein, embryonic ectoderm development (EED), and functions as a transcriptional repressor. Jin Q; van Eynde A; Beullens M; Roy N; Thiel G; Stalmans W; Bollen M J Biol Chem; 2003 Aug; 278(33):30677-85. PubMed ID: 12788942 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia-induced NIPP1 activation enhances metastatic potential and predicts poor prognosis in hepatocellular carcinoma. Huang Y; Tao Y; Hu K; Lin F; Li X; Feng T; Wang ZM Tumour Biol; 2016 Nov; 37(11):14903-14914. PubMed ID: 27644248 [TBL] [Abstract][Full Text] [Related]
13. A role for PP1/NIPP1 in steering migration of human cancer cells. Martin-Granados C; Prescott AR; Van Dessel N; Van Eynde A; Arocena M; Klaska IP; Görnemann J; Beullens M; Bollen M; Forrester JV; McCaig CD PLoS One; 2012; 7(7):e40769. PubMed ID: 22815811 [TBL] [Abstract][Full Text] [Related]
14. The C-terminus of NIPP1 (nuclear inhibitor of protein phosphatase-1) contains a novel binding site for protein phosphatase-1 that is controlled by tyrosine phosphorylation and RNA binding. Beullens M; Vulsteke V; Van Eynde A; Jagiello I; Stalmans W; Bollen M Biochem J; 2000 Dec; 352 Pt 3(Pt 3):651-8. PubMed ID: 11104670 [TBL] [Abstract][Full Text] [Related]
15. The molecular basis for substrate specificity of the nuclear NIPP1:PP1 holoenzyme. O'Connell N; Nichols SR; Heroes E; Beullens M; Bollen M; Peti W; Page R Structure; 2012 Oct; 20(10):1746-56. PubMed ID: 22940584 [TBL] [Abstract][Full Text] [Related]
16. Regulation of protein phosphatase 1gamma activity in hypoxia through increased interaction with NIPP1: implications for cellular metabolism. Comerford KM; Leonard MO; Cummins EP; Fitzgerald KT; Beullens M; Bollen M; Taylor CT J Cell Physiol; 2006 Oct; 209(1):211-8. PubMed ID: 16826568 [TBL] [Abstract][Full Text] [Related]
17. Nuclear organisation of NIPP1, a regulatory subunit of protein phosphatase 1 that associates with pre-mRNA splicing factors. Trinkle-Mulcahy L; Ajuh P; Prescott A; Claverie-Martin F; Cohen S; Lamond AI; Cohen P J Cell Sci; 1999 Jan; 112 ( Pt 2)():157-68. PubMed ID: 9858469 [TBL] [Abstract][Full Text] [Related]
18. The selective inhibition of protein phosphatase-1 results in mitotic catastrophe and impaired tumor growth. Winkler C; De Munter S; Van Dessel N; Lesage B; Heroes E; Boens S; Beullens M; Van Eynde A; Bollen M J Cell Sci; 2015 Dec; 128(24):4526-37. PubMed ID: 26542020 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylation-dependent interaction between the splicing factors SAP155 and NIPP1. Boudrez A; Beullens M; Waelkens E; Stalmans W; Bollen M J Biol Chem; 2002 Aug; 277(35):31834-41. PubMed ID: 12105215 [TBL] [Abstract][Full Text] [Related]
20. Nuclear and subnuclear targeting sequences of the protein phosphatase-1 regulator NIPP1. Jagiello I; Van Eynde A; Vulsteke V; Beullens M; Boudrez A; Keppens S; Stalmans W; Bollen M J Cell Sci; 2000 Nov; 113 Pt 21():3761-8. PubMed ID: 11034904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]